Detailed insights from HTA reports across major European agencies
Estimate probability of recommendations aligned with your targets
What is NaviHTA™?
A powerful tool that enables data-driven market access strategies and competitive positioning through rigorous analysis of historical HTA decisions.
Access detailed insights from Health Technology Assessment (HTA) reports across major European agencies for data-driven market access strategies.
Leverage machine-learning models to predict HTA appraisal outcomes based on a Target Product Profile.
.
Benchmark products against competitors to identify optimal positioning and differentiation strategies.
Identify and analyze factors that influence positive HTA outcomes across different agencies and therapeutic areas.
Coverage & Data Quality
NaviHTA delivers comprehensive coverage across major HTA agencies with a rigorous quality assurance process.
HAS, NICE, SMC, GBA-IQWIG
Since January 2018 (3-month delay)
All therapeutic areas
Quality-Assured Data Extraction Process
Using 200-point questionnaire
.
.
Structured, reproducible processes, with intensive analyst training
Two rounds of manual QC
.
.
With AI support
.
.
Rich & Comprehensive Data
NaviHTA provides extensive data coverage and keeps growing.
*As of April 2025
Accurate predictions, with explainability
F1 score: 0.95
Probability of actual ASMR category according predicted ASMR category
Example: If the predicted ASMR category if V, there is a 94% chance that the product actually receives an ASMR V.
Each probability estimate is accompanied by an analysis of influential factors, as illustrated by the example below.
Top 10 factors influencing the probability of ASMR I to IV for a product
This figure is for illustrative purpose only. The influence of different factors vary according to the context..
Strategic Applications
NaviHTA enables market access teams to make data-driven decisions across the product lifecycle.